Bos taurus · seed P00760 · 246 aa · family defined as ≥30% identity to that seed · compiled 07 October 2026
Open in CODSWALLOP UniProt P00760 RCSB by accession PDBe-KB AlphaFold DB InterPro CATH 2.40.10.10 SCOP 8042128 SCOP 8037496 SCOP 8035341 SCOP 8044201 SCOP 8042234 SCOP 8036522 SCOP 8042143 SCOP 8035635 SCOP 8041386 SCOP 8033466 SCOP 8042267 SCOP 8042216 RCSB 1NTP PDBe
CATH and SCOP identifiers come from the RCSB's own structure annotations, which the Domains panel already reads, so these are looked up rather than guessed at.
Every figure here is counted over the whole family rather than quoted from one entry.
1NTP, the structure every other member of this family is superposed onto. Rendered by the RCSB and embedded here: the live app shows an interactive viewport, which a document that fetches nothing cannot.
How many of this family's constructs contain each residue of the seed. A trough is a stretch nobody has put in a construct, which is a construct-design answer rather than a disorder one.
414 distinct constructs across 1,915 entries. 1,825 polymer entities differ from the UniProt canonical sequence in some way, 78 carry a recognised expression tag and 3 carry a fusion partner.
"Differs from canonical" is not the same as "engineered". The canonical sequence is the full gene product, so a secreted protein whose structures all start after its signal peptide counts every one of them as different: lysozyme's most-used construct, residues 19–147 on 1,239 entities, is simply the mature protein. Read the construct column below for what was actually done, rather than this count.
| Entities | Length | Best (Å) | Best entry | What was made |
|---|---|---|---|---|
| 486 | 223 | 0.75 | 4I8H | residues 24-246 |
| 102 | 254 | 1.36 | 5PAG | residues 213-466 |
| 57 | 131 | 1.00 | 5R43 | residues 16-146 |
| 55 | 97 | 1.00 | 5R43 | residues 149-245 |
| 46 | 254 | 1.55 | 4Y6D | residues 235-488 |
| 37 | 244 | 1.55 | 5TKS | His6; residues 388-625; N491G, T493G |
| 34 | 245 | 1.70 | 1T8O | matches the canonical sequence |
| 30 | 253 | 1.40 | 6XVD | residues 179-431; C299A, N322Q |
| 28 | 234 | 1.50 | 2PR3 | residues 235-468 |
| 28 | 238 | 0.92 | 7MBO | residues 388-625; C500S |
| 25 | 246 | 0.91 | 4XOJ | matches the canonical sequence |
| 23 | 229 | 1.50 | 1BTY | residues 18-246 |
| 23 | 238 | 1.25 | 4CRG | residues 388-625; S452A, K455A, T493A +1 more |
| 22 | 223 | 1.25 | 1S83 | residues 9-231 |
| 19 | 246 | 1.18 | 5YC6 | residues 179-424; C299A, N322Q |
| 18 | 226 | 1.13 | 7H66 | residues 22-247; C28S, F135K |
| 17 | 224 | 0.80 | 1PQ7 | residues 25-248 |
| 17 | 245 | 1.45 | 5Z1C | residues 179-423; C299A, N322Q |
| 17 | 245 | 1.65 | 4MPU | residues 31-275; R51H, D52G, R53P +1 more |
| 17 | 259 | 1.32 | 2UUJ | residues 364-622 |
| 16 | 223 | 1.00 | 4K8Y | residues 31-253; H197Q |
| 16 | 232 | 1.17 | 5NAT | residues 26-253 |
| 16 | 235 | 1.90 | 1G2L | residues 235-469 |
| 15 | 233 | 1.62 | 2P3U | residues 235-467 |
| 14 | 243 | 1.15 | 1UTN | residues 4-246 |
Showing the 25 most-used of 414.
Columns where the wild-type residue still dominates but a real minority carries something else, which is a different question from "what varies across species".
| Oligomeric state | Chains | Entries | Share |
|---|---|---|---|
| monomeric | 1 | 959 | 50.1% |
| dimeric | 2 | 620 | 32.4% |
| trimeric | 3 | 159 | 8.3% |
| tetrameric | 4 | 97 | 5.1% |
| pentameric | 5 | 28 | 1.5% |
| hexameric | 6 | 27 | 1.4% |
| octameric | 8 | 17 | 0.9% |
| dodecameric | 12 | 5 | 0.3% |
1,182 entries have the depositor's assembly corroborated by PISA, 670 carry the depositor's word alone and 63 were assigned by PISA where the depositor gave none. The middle figure is not a disagreement: PISA may have returned nothing or never run. 93 entries carry more than one assembly with different chain counts, so they have no single answer to quote: 1AB9, 1BML, 1BQY, 1CBW, 1DLK, 1FIZ, 1GGD, 1GHB, 1GMH, 1K2I, 1KLI, 1L4D, 1L4Z, 1MTN, 1OPH, 1P2J, 1P2M, 1P2N, 1P2O, 1P2Q.
Every source's own domains on the seed axis, one row each. They are not merged: Pfam, CATH, SCOP and InterPro disagree about boundaries, and a merged track would state a consensus none of them gave.
| Domain | Source | Span (seed) | Chains |
|---|---|---|---|
| Trypsin-like serine proteases | CATH 2.40.10.10 | 126–232 | 4,662 |
| Trypsin-like serine proteases | SCOP2B 8042128 | 23–246 | 28 |
| Trypsin-like serine proteases | SCOP2B 8037496 | 24–246 | 531 |
| Trypsin-like serine proteases | SCOP2B 8035341 | 24–246 | 129 |
| Trypsin-like serine proteases | SCOP2B 8044201 | 24–246 | 105 |
| Trypsin-like serine proteases | SCOP2B 8042234 | 24–246 | 36 |
| Trypsin-like serine proteases | SCOP2B 8036522 | 24–246 | 33 |
| Trypsin-like serine proteases | SCOP2B 8042143 | 24–246 | 23 |
| Trypsin-like serine proteases | SCOP2B 8035635 | 24–246 | 22 |
| Trypsin-like serine proteases | SCOP2B 8041386 | 24–244 | 20 |
| Trypsin-like serine proteases | SCOP2B 8033466 | 26–246 | 36 |
| Trypsin-like serine proteases | SCOP2B 8042267 | 26–246 | 22 |
| Component | Class | Name | Entries | Best (Å) |
|---|---|---|---|---|
| CA | ion | Calcium Ion | 972 | 0.75 |
| SO4 | ion | Sulfate Ion | 712 | 0.75 |
| GOL | cryoprotectant | Glycerol | 322 | 0.75 |
| BEN | ligand | Benzamidine | 184 | 0.75 |
| CL | ion | Chloride Ion | 144 | 1.15 |
| EDO | cryoprotectant | 1,2-Ethanediol | 122 | 0.91 |
| NAG | cofactor | 2-Acetamido-2-Deoxy-Beta-D-Glucopyranose | 120 | 0.92 |
| NA | ion | Sodium Ion | 106 | 0.91 |
| DMS | cryoprotectant | Dimethyl Sulfoxide | 103 | 0.95 |
| ZN | ion | Zinc Ion | 63 | 1.13 |
| ACT | cryoprotectant | Acetate Ion | 60 | 0.93 |
| MG | ion | Magnesium Ion | 54 | 1.25 |
| CIT | buffer | Citric Acid | 40 | 1.00 |
| FUC | cofactor | Alpha-L-Fucopyranose | 35 | 1.25 |
| PO4 | ion | Phosphate Ion | 25 | 1.16 |
| PEG | cryoprotectant | Di(Hydroxyethyl)ether | 25 | 1.18 |
| BGC | ligand | Beta-D-Glucopyranose | 22 | 1.72 |
| PGE | cryoprotectant | Triethylene Glycol | 21 | 1.18 |
| MES | buffer | 2-(N-Morpholino)-Ethanesulfonic Acid | 20 | 0.97 |
| PG4 | cryoprotectant | Tetraethylene Glycol | 20 | 1.18 |
Parsed from the free text 1,578 depositors typed into
_exptl_crystal_grow.pdbx_details, out of 1,671
entries that recorded anything at all.
Median pH 7.0
(range 2.0 to 10.5).
1,913 entries carry a wwPDB validation report: 1,069 clean, 532 worth a check and 312 with something to explain. Median clashscore 5.1, median RSRZ outliers 2.24%, median R-free minus R-work 0.035. 1,722 have released structure factors.
| Organism | Entries | Best (Å) | Ligand-bound | Seed covered |
|---|---|---|---|---|
| Homo sapiens | 1,019 | 0.92 | 792 | 100% |
| Bos taurus | 711 | 0.75 | 515 | 100% |
| Sus scrofa | 52 | 1.18 | 20 | 94% |
| Rattus norvegicus | 30 | 1.46 | 6 | 100% |
| Mus musculus | 19 | 1.25 | 9 | 91% |
| Fusarium oxysporum | 17 | 0.80 | 4 | 85% |
| Salmo salar | 11 | 1.00 | 7 | 100% |
| Rattus rattus | 11 | 1.59 | 7 | 94% |
| Streptomyces griseus | 7 | 1.05 | 3 | 88% |
| Saccharopolyspora erythraea | 5 | 0.78 | 0 | 89% |
| Oncorhynchus keta | 4 | 1.55 | 4 | 90% |
| Daboia siamensis | 4 | 1.80 | 4 | 91% |
246 residues, numbered every ten. Every identity figure in this document is measured against this sequence.
active or binding site modified residue or glycosylation disulphide cysteine transmembrane or signal the 15 most-substituted positions
Sites are UniProt's curated features where the seed is a UniProt accession; the substituted positions are measured from this family's own alignment rather than annotated, and only the fifteen most substituted are marked: every position carrying a minority substitution would be most of the protein, because the family holds orthologues. A residue can carry more than one and is drawn with the first that applies, in the order of the key above.
One record per paper, not per entry.
| Year | Citation |
|---|---|
| 2026 | The CASP 16 Experimental Protein-Ligand Datasets. Proteins doi:10.1002/prot.70053 |
| 2026 | X-ray Diffraction Analyses of Trypsin Crystals Grown in the Presence of Additives Cryst.Growth Des. doi:10.1021/acs.cgd.5c01305 |
| 2026 | A 3.3- angstrom cryo-EM structure of an engineered high-affinity human prothrombinase complex. Blood doi:10.1182/blood.2025031527 |
| 2026 | N ‐Alkyl and N ‐Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy to Identify Orally Bioavailable Plasma Kallikrein Inhibitors. Acs Med.Chem.Lett. doi:10.1021/acsmedchemlett.6c00066 |
| 2026 | Exosite-mediated targeting of GSDMB by dimeric granzyme A in lymphocyte pyroptotic killing. Immunity doi:10.1016/j.immuni.2025.12.009 |
| 2026 | TMPRSS2-mediated coronavirus spike activation and inhibition. Nat.Struct.Mol.Biol. doi:10.1038/s41594-026-01801-y |
| 2026 | Complete inhibition of beta-tryptase by tetramer dissociation and active site allostery due to a single antibody residue. Nat Commun doi:10.1038/s41467-026-70491-3 |
| 2026 | Anticoagulation with mechanistically distinct FXI/FXIa antibodies amrecibart (REGN9933A2) and cenvacibart (REGN7508Cat). Blood doi:10.1182/blood.2025032276 |
| 2026 | Structural insights into the exosite-mediated activation of factor IX by factor XIa using cryogenic electron microscopy. J.Thromb.Haemost. doi:10.1016/j.jtha.2026.08.015 |
| 2026 | Prothrombinase processivity is conferred by substrate allostery. Embo J. doi:10.1038/s44318-026-00782-4 |
| 2026 | Structural requirements of blood factors binding to soluble hexon trimers with implications for adenovirus cell targeting and immune evasion. Plos Pathog. doi:10.1371/journal.ppat.1014389 |
| 2026 | Molecular mechanism of cleavage at R271 during prothrombin activation revealed by cryo-EM. Blood doi:10.1182/blood.2025032364 |
| 2025 | Large Library Docking and Biophysical Analysis of Small-Molecule TMPRSS2 Inhibitors. J.Med.Chem. doi:10.1021/acs.jmedchem.4c03089 |
| 2025 | Structural basis of TMPRSS11D specificity and autocleavage activation. Nat Commun doi:10.1038/s41467-025-59677-3 |
| 2025 | Discovery of an autoinhibited conformation in mesotrypsin reveals a strategy for selective serine protease inhibition. Sci Adv doi:10.1126/sciadv.adu9129 |
| 2025 | Small molecule inhibitors of mannan-binding lectin-associated serine Proteases-2 and-3. Eur.J.Med.Chem. doi:10.1016/j.ejmech.2025.117238 |
| 2025 | Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus Resolution. J.Med.Chem. doi:10.1021/acs.jmedchem.4c01819 |
| 2025 | The crystal structure of coronavirus RBD-TMPRSS2 complex provides basis for the discovery of therapeutic antibodies. Nat Commun doi:10.1038/s41467-025-62023-2 |
| 2025 | Integrating Surface Plasmon Resonance and Docking Analysis for Mechanistic Insights of Tryptase Inhibitors. Molecules doi:10.3390/molecules30061338 |
| 2025 | The in vitro and crystallographic studies reveal the inhibitory potential of vitamin B 6 analogues against a serine protease trypsin. Int.J.Biol.Macromol. doi:10.1016/j.ijbiomac.2025.142433 |
| 2025 | Discovery of BAY 3389934 Hydrochloride: A Potent and Selective Small-Molecule Dual Factor IIa/Xa Inhibitor with Short Half-Life for the Acute Treatment of Sepsis-Induced Coagulopathy. J.Med.Chem. doi:10.1021/acs.jmedchem.5c00538 |
| 2025 | Structural determination of a new non-canonical inhibition complex between porcine trypsin and M271 a potato Kunitz-STI inhibitor. Biochem.Biophys.Res.Commun. doi:10.1016/j.bbrc.2025.151818 |
| 2025 | Screening macrocyclic peptide libraries by yeast display allows control of selection process and affinity ranking. Nat Commun doi:10.1038/s41467-025-60907-x |
| 2025 | Molecular basis of vitamin K-dependent protein gamma-glutamyl carboxylation. Cell Res. doi:10.1038/s41422-025-01185-6 |
| 2025 | Cryo-EM structure of coagulation factor Va bound to activated protein C. Blood doi:10.1182/blood.2025028476 |
| 2025 | Monoclonal antibodies against human TMPRSS2 prevent infection by any SARS-CoV-2 variant. Iscience doi:10.1016/j.isci.2025.113424 |
| 2025 | A TMPRSS6-inhibiting mAb improves disease in a beta-thalassemia mouse model and reduces iron in healthy humans. JCI Insight doi:10.1172/jci.insight.191813 |
| 2025 | Cryo-EM structure of the tissue factor/factor VIIa complex with a factor X mimetic reveals a novel allosteric mechanism. Blood doi:10.1182/blood.2025029430 |
| 2025 | A surface lipoprotein on Pasteurella multocida binds complement factor I to promote immune evasion. Plos Pathog. doi:10.1371/journal.ppat.1012686 |
| 2024 | Mechanism-Based Macrocyclic Inhibitors of Serine Proteases. J.Med.Chem. doi:10.1021/acs.jmedchem.3c02388 |
| 2024 | Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsin. Protein Sci. doi:10.1002/pro.5110 |
| 2024 | Alternative Linkage Chemistries in the Chemoenzymatic Synthesis of Microviridin-Based Cyclic Peptides. Org.Lett. doi:10.1021/acs.orglett.3c04045 |
| 2024 | Water-medicated specifically targeting the S1 pockets among serine proteases using an arginine analogue. Bioorg.Chem. doi:10.1016/j.bioorg.2024.107734 |
| 2024 | Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus. Cell doi:10.1016/j.cell.2024.06.007 |
| 2024 | An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa. Proc.Natl.Acad.Sci.USA doi:10.1073/pnas.2401136121 |
| 2024 | S. aureus Eap is a polyvalent inhibitor of neutrophil serine proteases. J.Biol.Chem. doi:10.1016/j.jbc.2024.107627 |
| 2024 | Structural basis for the binding of famotidine, cimetidine, guanidine, and pimagedine with serine protease. Biochem.Biophys.Res.Commun. doi:10.1016/j.bbrc.2024.150603 |
| 2024 | Kunitz-type trypsin inhibitor from durian (Durio zibethinus) employs a distinct loop for trypsin inhibition. Protein Sci. doi:10.1002/pro.5230 |
| 2024 | Macrocyclic Inhibitors Targeting the Prime Site of the Fibrinolytic Serine Protease Plasmin. Chemmedchem doi:10.1002/cmdc.202400360 |
| 2024 | Crystal structure of the Michaelis complex of trypsin with N-alpha-benzoyl-l-arginine ethyl ester J Chin Chem Soc doi:10.1002/jccs.202400214 |